Bank of America’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $268K | Buy |
57,715
+3,853
| +7% | +$9.99K | ﹤0.01% | 5245 |
|
|
2026
Q1 | $150K | Buy |
53,862
+28,799
| +115% | +$87.6K | ﹤0.01% | 5446 |
|
|
2025
Q4 | $104K | Sell |
25,063
-264
| -1% | -$1.39K | ﹤0.01% | 5610 |
|
|
2025
Q3 | $107K | Buy |
25,327
+14,285
| +129% | +$53.7K | ﹤0.01% | 6568 |
|
|
2025
Q2 | $23.3K | Sell |
11,042
-3,766
| -25% | -$5.63K | ﹤0.01% | 7025 |
|
|
2025
Q1 | $18.1K | Sell |
14,808
-23,550
| -61% | -$33K | ﹤0.01% | 6995 |
|
|
2024
Q4 | $49.5K | Buy |
38,358
+19,316
| +101% | +$46.3K | ﹤0.01% | 6641 |
|
|
2024
Q3 | $52.4K | Buy |
19,042
+686
| +4% | +$1.69K | ﹤0.01% | 6527 |
|
|
2024
Q2 | $41.5K | Buy |
18,356
+3,623
| +25% | +$11K | ﹤0.01% | 6562 |
|
|
2024
Q1 | $35.2K | Buy |
14,733
+9,101
| +162% | +$17.2K | ﹤0.01% | 6611 |
|
|
2023
Q4 | $9.35K | Buy |
5,632
+27
| +0.5% | +$52 | ﹤0.01% | 6916 |
|
|
2023
Q3 | $10.8K | Hold |
5,605
| – | – | ﹤0.01% | 6844 |
|
|
2023
Q2 | $8.07K | Hold |
5,605
| – | – | ﹤0.01% | 6909 |
|
|
2023
Q1 | $11.8K | Sell |
5,605
-340
| -6% | -$549 | ﹤0.01% | 6886 |
|
|
2022
Q4 | $6.72K | Sell |
5,945
-2
| -0% | -$3 | ﹤0.01% | 7006 |
|
|
2022
Q3 | $10K | Sell |
5,947
-1,850
| -24% | -$3.46K | ﹤0.01% | 7234 |
|
|
2022
Q2 | $10K | Sell |
7,797
-1,800
| -19% | -$2.59K | ﹤0.01% | 7386 |
|
|
2022
Q1 | $15K | Buy |
9,597
+3,044
| +46% | +$5.89K | ﹤0.01% | 7620 |
|
|
2021
Q4 | $14K | Buy |
6,553
+1,036
| +19% | +$2.96K | ﹤0.01% | 7620 |
|
|
2021
Q3 | $21K | Sell |
5,517
-6,700
| -55% | -$22.7K | ﹤0.01% | 7370 |
|
|
2021
Q2 | $40K | Sell |
12,217
-35,406
| -74% | -$126K | ﹤0.01% | 6923 |
|
|
2021
Q1 | $103K | Buy |
47,623
+36,832
| +341% | +$82.5K | ﹤0.01% | 6373 |
|
|
2020
Q4 | $24K | Buy |
10,791
+3,265
| +43% | +$8.57K | ﹤0.01% | 6547 |
|
|
2020
Q3 | $20K | Sell |
7,526
-3,369
| -31% | -$9.43K | ﹤0.01% | 6281 |
|
|
2020
Q2 | $33K | Buy |
10,895
+6,462
| +146% | +$16.3K | ﹤0.01% | 6134 |
|
|
2020
Q1 | $9K | Sell |
4,433
-5,309
| -54% | -$12.9K | ﹤0.01% | 6385 |
|
|
2019
Q4 | $27K | Sell |
9,742
-1,334
| -12% | -$4.63K | ﹤0.01% | 6435 |
|
|
2019
Q3 | $40K | Buy |
11,076
+266
| +2% | +$961 | ﹤0.01% | 6388 |
|
|
2019
Q2 | $44K | Sell |
10,810
-11,219
| -51% | -$48.6K | ﹤0.01% | 6352 |
|
|
2019
Q1 | $112K | Buy |
22,029
+17,629
| +401% | +$84.6K | ﹤0.01% | 5823 |
|
|
2018
Q4 | $15K | Sell |
4,400
-1,975
| -31% | -$9.43K | ﹤0.01% | 6551 |
|
|
2018
Q3 | $38K | Buy |
6,375
+3,375
| +113% | +$18.6K | ﹤0.01% | 6320 |
|
|
2018
Q2 | $19K | Sell |
3,000
-5,260
| -64% | -$25.6K | ﹤0.01% | 6522 |
|
|
2018
Q1 | $39K | Buy |
8,260
+1,010
| +14% | +$4.71K | ﹤0.01% | 6137 |
|
|
2017
Q4 | $24K | Sell |
7,250
-353
| -5% | -$892 | ﹤0.01% | 6360 |
|
|
2017
Q3 | $16K | Buy |
7,603
+1,853
| +32% | +$3.67K | ﹤0.01% | 6362 |
|
|
2017
Q2 | $14K | Sell |
5,750
-78
| -1% | -$208 | ﹤0.01% | 6331 |
|
|
2017
Q1 | $13K | Sell |
5,828
-3,480
| -37% | -$5.25K | ﹤0.01% | 6460 |
|
|
2016
Q4 | $9K | Sell |
9,308
-2
| -0% | -$2 | ﹤0.01% | 6582 |
|
|
2016
Q3 | $10K | Sell |
9,310
-449
| -5% | -$798 | ﹤0.01% | 6386 |
|
|
2016
Q2 | $15K | Sell |
9,759
-418
| -4% | -$613 | ﹤0.01% | 6354 |
|
|
2016
Q1 | $15K | Hold |
10,177
| – | – | ﹤0.01% | 6245 |
|
|
2015
Q4 | $17K | Sell |
10,177
-6,640
| -39% | -$15.2K | ﹤0.01% | 6476 |
|
|
2015
Q3 | $39K | Sell |
16,817
-798
| -5% | -$1.88K | ﹤0.01% | 6043 |
|
|
2015
Q2 | $48K | Sell |
17,615
-81
| -0.5% | -$244 | ﹤0.01% | 5953 |
|
|
2015
Q1 | $60K | Buy |
17,696
+6,979
| +65% | +$24.9K | ﹤0.01% | 5574 |
|
|
2014
Q4 | $37K | Sell |
10,717
-5,904
| -36% | -$26.1K | ﹤0.01% | 6503 |
|
|
2014
Q3 | $84K | Buy |
16,621
+11,254
| +210% | +$87.6K | ﹤0.01% | 6142 |
|
|
2014
Q2 | $75K | Sell |
5,367
-1,700
| -24% | -$21.2K | ﹤0.01% | 6350 |
|
|
2014
Q1 | $108K | Buy |
7,067
+5,022
| +246% | +$71.5K | ﹤0.01% | 5934 |
|
|
2013
Q4 | $16K | Buy |
+2,045
| New | +$18.9K | ﹤0.01% | 7113 |
|
|
2013
Q3 | – | Sell |
-44
| Closed | – | – | 7926 |
|
|
2013
Q2 | $0 | Buy |
+44
| New | +$180 | ﹤0.01% | 7707 |
|
Other funds holding GALT
WANY
Bank of America's GALT Position: Q2 2026 in Review
Bank of America increased its Galectin Therapeutics (GALT) stake by 7.2% in Q2 2026, buying an estimated $9.99K and bringing the position to 57,715 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #5245.
Bank of America first reported a position in GALT in Q2 2013 and has held it in 52 quarters since. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.
- Bank of America held 57,715 shares of Galectin Therapeutics worth $268K as of Q2 2026.
- Bank of America bought 3,853 Galectin Therapeutics shares in Q2 2026, an estimated $9.99K.
- Galectin Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5245 holding.
- Bank of America first reported a position in Galectin Therapeutics in Q2 2013 and has held it in 52 quarters since.
- 98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.